Clindamycin and Ketoconazole Drug Interaction
There is no clinically significant pharmacokinetic interaction between clindamycin and ketoconazole, and these agents can be safely co-administered without dose adjustment. The FDA ketoconazole label does not list clindamycin among drugs requiring caution, contraindication, or monitoring when used with ketoconazole 1.
Mechanism and Safety Profile
Ketoconazole is a potent CYP3A4 inhibitor and P-glycoprotein inhibitor that increases plasma concentrations of drugs metabolized through these pathways 1. However, clindamycin is not primarily metabolized by CYP3A4, which explains the absence of a meaningful interaction between these two agents.
The FDA label for ketoconazole extensively details drug interactions across multiple classes—including antibacterials like rifabutin and telithromycin—but clindamycin is notably absent from all interaction categories (contraindicated, not recommended, or use with caution) 1. This omission is clinically significant and indicates no recognized interaction risk.
Clinical Evidence Supporting Co-Administration
Multiple studies demonstrate the safe and effective combination of clindamycin with ketoconazole in vaginal formulations for treating mixed vaginitis:
- A randomized study of 105 pregnant patients showed the ketoconazole-clindamycin combination was effective with no adverse events reported 2
- A 169-patient multicenter trial found the combination well-tolerated with no adverse events during treatment 3
- A comparative study showed similar efficacy and safety, with no adverse reactions reported 4
- Latin American gynecologists prescribe this combination as preferred treatment for mixed vaginitis, with 97% reporting very good to excellent results 5
Important Caveats
Clindamycin-Rifampin Interaction (Not Ketoconazole)
Do not confuse this with the clinically significant clindamycin-rifampin interaction, where rifampin (a CYP3A4 inducer) dramatically increases clindamycin clearance—particularly with oral administration (18.8-fold increase in clearance) 6. This is a separate issue unrelated to ketoconazole.
Ketoconazole's Other Interactions
While ketoconazole does not interact with clindamycin, it has extensive interactions with other drug classes that require vigilance 1:
- Contraindicated: QT-prolonging drugs (pimozide, quinidine, disopyramide, dofetilide, dronedarone), ergot alkaloids, certain statins (lovastatin, simvastatin), methadone, ranolazine
- Use with caution: Immunosuppressants (cyclosporine, tacrolimus), anticoagulants, benzodiazepines, calcium channel blockers
Practical Management
No dose adjustment or special monitoring is required when co-administering clindamycin and ketoconazole. Prescribe both agents at standard therapeutic doses based on the indication being treated. The combination has been used safely in both topical vaginal formulations and when both agents are given systemically.
Focus monitoring efforts on ketoconazole's well-documented interactions with other concomitant medications the patient may be taking, particularly those metabolized by CYP3A4 or transported by P-glycoprotein 1.